Profile
Lawrence Steinman is an American neurologist, neuroimmunologist and an academic. He is a Professor of Neurology and Neurological Sciences and Pediatrics at Stanford University.
| Role | Director |
|---|---|
| Notability | 60/100 |
| Links | Wikipedia |
Updated Jul 16, 2026
STEINMAN LAWRENCE has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $100K.
Lawrence Steinman is an American neurologist, neuroimmunologist and an academic. He is a Professor of Neurology and Neurological Sciences and Pediatrics at Stanford University.
| Role | Director |
|---|---|
| Notability | 60/100 |
| Links | Wikipedia |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-12-01 | KTTA | Pasithea Therapeutics Corp. | P — Open-market purchase | 133.3K | $0.75 | $100K |
| 2025-06-18 | BCAB | BioAtla, Inc. | A — Grant or award | 23.5K | $0.00 | |
| 2025-06-17 | FRMM | FORUM MARKETS Inc | A — Grant or award | 45.0K | $0.00 |
Lawrence Steinman is an American neurologist, neuroimmunologist and an academic. He is a Professor of Neurology and Neurological Sciences and Pediatrics at Stanford University.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchases ($100K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live STEINMAN LAWRENCE profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.